Screener
Castle Biosciences CSTL Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
FAQ
- What is Castle Biosciences's short-term investments?
- Castle Biosciences (CSTL) reported short-term investments of $5.6M in Q1 2026.
- How has Castle Biosciences's short-term investments changed year-over-year?
- Castle Biosciences's short-term investments decreased by 96.9% year-over-year, from $183.33M to $5.6M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Castle Biosciences's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude